DrugPatentWatch Database Preview
Drugs in MeSH Category Reverse Transcriptase Inhibitors
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | LAMIVUDINE | lamivudine | TABLET;ORAL | 077464-002 | Nov 21, 2016 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Mylan | LAMIVUDINE | lamivudine | TABLET;ORAL | 204528-002 | Mar 4, 2016 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Liaoning Chengda | ZIDOVUDINE | zidovudine | INJECTABLE;INJECTION | 204538-001 | Nov 26, 2013 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
